Actual Medicinal Product (AMP) - Augmentin 125/31 oral suspension (GlaxoSmithKline UK Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Augmentin 125/31 oral suspension | Start Date 01-10-2024 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
Codes
| Code | Start Date | End Date |
|---|---|---|
| 43646911000001105 | 01-10-2024 |
Parent Products
-
VTMCo-amoxiclav
-
VMPCo-amoxiclav 125mg/31mg/5ml oral suspension
-
AMP(Current) Augmentin 125/31 oral suspensi... (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 100 ml | 354 |